Peter D. Skillington
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Peter D. Skillington has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Marco Larobina
Cardio-thoracic Surgery, The Royal Melbourne Hospital
8 shared publicationsJames Tatoulis
University of Melbourne, Melbourne, Victoria, Australia; Department of Cardiothoracic Surgery, Royal Melbourne Hospital, Melbourne, Victoria, Australia
3 shared publications- Johanna Josepha Maria Takkenberg
Department of Cardiothoracic Surgery, Erasmus University Medical Center, Rotterdam, Netherlands
3 shared publications Leeanne Grigg
Department of Cardiology, Royal Melbourne Hospital, Melbourne, Vic, Australia
3 shared publicationsM. Mostafa Mokhles
Department of Cardiothoracic Surgery, Erasmus University Medical Center, Rotterdam, the Netherlands
3 shared publicationsEdward Buratto
Department of Cardiothoracic Surgery, Royal Melbourne Hospital, Melbourne, Australia
2 shared publications
Latest Publications
- 19 January 2025
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 170 (4) , 1017-1024.e1
Twenty-five years of the ross operation in adults: The inclusion technique keeps up the expectations
- 19 January 2025
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 170 (4) , 1017-1024.e1
Twenty-five years of the ross operation in adults: The inclusion technique keeps up the expectations
- 1 January 2022
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 113 (1) , 83-91
The Outcomes of the Inclusion Ross in Select Patients Aged ≥ 50 Years, Compared to a Younger Cohort
- 1 January 2022
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 113 (1) , 83-91
The Outcomes of the Inclusion Ross in Select Patients Aged ≥ 50 Years, Compared to a Younger Cohort
- Open Access
- 13 October 2021
- Published by Elsevier in JTCVS Techniques
- Vol. 10, 403-407
Right-sided reconstruction during the Ross procedure—A technical perspective for long-term durability
- 13 October 2021
- Published by Elsevier in JTCVS Techniques
- Vol. 10, 403-407
Open AccessRight-sided reconstruction during the Ross procedure—A technical perspective for long-term durability
- Open Access
- 1 July 2021
- Published by AME Publishing Company in Annals of Cardiothoracic Surgery
- Vol. 10 (4) , 541-543
The Ross inclusion technique
Video 1 The Ross inclusion technique. Authors: Peter D. Skillington, Campbell D. Flynn, Marco Larobina, Michael O’Keefe
- 1 July 2021
- Published by AME Publishing Company in Annals of Cardiothoracic Surgery
- Vol. 10 (4) , 541-543
Open AccessThe Ross inclusion technique
Video 1 The Ross inclusion technique. Authors: Peter D. Skillington, Campbell D. Flynn, Marco Larobina, Michael O’Keefe
- 29 March 2021
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 60 (4) , 939-946
Long-term outcomes of right ventricle-to-pulmonary artery conduit insertion in adults with congenital heart disease: survival analysis by National Death Index
: OBJECTIVES: The aim of this study was to investigate the long-term outcomes following right ventricle-to-pulmonary artery (RV-to-PA) conduit insertion of Medtronic Freestyle® porcine valve (MFV) or pulmonary allograft valve (PAV) in adult patients with congenital heart disease. METHODS: Retrospective medical record review of consecutive RV-to-PA conduit insertion, using either PAV or MFV from 1991 to 2017. Perioperative data and clinic reports were collected. Cause and date of death were obtained from the Australian National Death Index to obtain survival function. RESULTS: In total, 232 patients (median age 31.5 years, interquartile range 25–41 years) underwent RV-to-PA conduit insertion (PAV = 84 and MFV = 148) and were eligible for inclusion [63.8% tetralogy of Fallot (TOF); 11.6% congenital pulmonary stenosis (PS); 24.6% other diagnoses]. The overall median follow-up time was 9.1 years (interquartile range 5.3–12.6 years). The mean gradient was 11.8 ± 7.1 mmHg in PAV and 16.6 ± 9.6 mmHg in MFV patients. Congenital PS patients had 100% survival at 20 years, TOF patients at 5, 10, 15 and 20 years had 99%, 97%, 96% and 96% survival, respectively. Patients with other primary diagnoses at 5, 10, 15 and 20 years had 93%, 91%, 87% and 87% respectively. Freedom from reintervention did not differ significantly at 5 and 10 years between pulmonary allograft (98.6%, 98.6%) and Freestyle® porcine bioprosthesis (97.5%, 93%). CONCLUSIONS: Both valves perform equally well with regard to patients’ freedom from reoperation, although transvalvular gradient was higher for Freestyle® patients. Congenital PS and TOF patients had better survival than patients with other primary diagnoses.
- 29 March 2021
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 60 (4) , 939-946
Long-term outcomes of right ventricle-to-pulmonary artery conduit insertion in adults with congenital heart disease: survival analysis by National Death Index
: OBJECTIVES: The aim of this study was to investigate the long-term outcomes following right ventricle-to-pulmonary artery (RV-to-PA) conduit insertion of Medtronic Freestyle® porcine valve (MFV) or pulmonary allograft valve (PAV) in adult patients with congenital heart disease. METHODS: Retrospective medical record review of consecutive RV-to-PA conduit insertion, using either PAV or MFV from 1991 to 2017. Perioperative data and clinic reports were collected. Cause and date of death were obtained from the Australian National Death Index to obtain survival function. RESULTS: In total, 232 patients (median age 31.5 years, interquartile range 25–41 years) underwent RV-to-PA conduit insertion (PAV = 84 and MFV = 148) and were eligible for inclusion [63.8% tetralogy of Fallot (TOF); 11.6% congenital pulmonary stenosis (PS); 24.6% other diagnoses]. The overall median follow-up time was 9.1 years (interquartile range 5.3–12.6 years). The mean gradient was 11.8 ± 7.1 mmHg in PAV and 16.6 ± 9.6 mmHg in MFV patients. Congenital PS patients had 100% survival at 20 years, TOF patients at 5, 10, 15 and 20 years had 99%, 97%, 96% and 96% survival, respectively. Patients with other primary diagnoses at 5, 10, 15 and 20 years had 93%, 91%, 87% and 87% respectively. Freedom from reintervention did not differ significantly at 5 and 10 years between pulmonary allograft (98.6%, 98.6%) and Freestyle® porcine bioprosthesis (97.5%, 93%). CONCLUSIONS: Both valves perform equally well with regard to patients’ freedom from reoperation, although transvalvular gradient was higher for Freestyle® patients. Congenital PS and TOF patients had better survival than patients with other primary diagnoses.
- 1 February 2015
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 149 (2) , S46-S52
The Ross procedure using autologous support of the pulmonary autograft: Techniques and late results
- 1 February 2015
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 149 (2) , S46-S52
The Ross procedure using autologous support of the pulmonary autograft: Techniques and late results
- Open Access
- 1 September 2013
- Published by Global Cardiology Science and Practice in Global Cardiology Science and Practice
- Vol. 2013 (4) , 383-94
Inclusion cylinder method for aortic valve replacement utilising the Ross operation in adults with predominant aortic stenosis - 99% freedom from re-operation on the aortic valve at 15 years
To report our experience with the Ross operation in patients with predominant aortic stenosis (AS) using an inclusion cylinder (IC) method. Out of 324 adults undergoing a Ross operation, 204 patients of mean age of 41.3 years (limits 16-62) underwent this procedure for either AS or mixed AS and regurgitation (AS/AR) between October, 1992 and February, 2012, implanting the PA with an IC method. Clinical follow up and serial echo data for this group is 97% complete with late mortality follow up 99% complete. There has been zero (0%) early mortality, and late survival at 15 years is 98% (96%, 100%). Only one re-operation on the aortic valve for progressive aortic regurgitation (AR) has been required with freedom from re-operation on the aortic valve at 15 years being 99% (96%, 100%). The freedom from all re-operations on the aortic and pulmonary valves at 15 years is 97% (94%, 100%). Echo analysis at the most recent study shows that 98% have nil, trivial or mild AR. Aortic root size has remained stable, shown by long-term (15 year) echo follow up. In an experience spanning 19 years, the Ross operation used for predominant AS using the IC method described, results in 99% freedom from re-operation on the aortic valve at 15 years, better than any other tissue or mechanical valve. For adults under 65 years without significant co-morbidities who present with predominant AS, the pulmonary autograft inserted with this technique gives excellent results.
- 1 September 2013
- Published by Global Cardiology Science and Practice in Global Cardiology Science and Practice
- Vol. 2013 (4) , 383-94
Open AccessInclusion cylinder method for aortic valve replacement utilising the Ross operation in adults with predominant aortic stenosis - 99% freedom from re-operation on the aortic valve at 15 years
To report our experience with the Ross operation in patients with predominant aortic stenosis (AS) using an inclusion cylinder (IC) method. Out of 324 adults undergoing a Ross operation, 204 patients of mean age of 41.3 years (limits 16-62) underwent this procedure for either AS or mixed AS and regurgitation (AS/AR) between October, 1992 and February, 2012, implanting the PA with an IC method. Clinical follow up and serial echo data for this group is 97% complete with late mortality follow up 99% complete. There has been zero (0%) early mortality, and late survival at 15 years is 98% (96%, 100%). Only one re-operation on the aortic valve for progressive aortic regurgitation (AR) has been required with freedom from re-operation on the aortic valve at 15 years being 99% (96%, 100%). The freedom from all re-operations on the aortic and pulmonary valves at 15 years is 97% (94%, 100%). Echo analysis at the most recent study shows that 98% have nil, trivial or mild AR. Aortic root size has remained stable, shown by long-term (15 year) echo follow up. In an experience spanning 19 years, the Ross operation used for predominant AS using the IC method described, results in 99% freedom from re-operation on the aortic valve at 15 years, better than any other tissue or mechanical valve. For adults under 65 years without significant co-morbidities who present with predominant AS, the pulmonary autograft inserted with this technique gives excellent results.
- 1 September 2013
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 96 (3) , 823-829
Twenty-Year Analysis of Autologous Support of the Pulmonary Autograft in the Ross Procedure
- 1 September 2013
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 96 (3) , 823-829
Twenty-Year Analysis of Autologous Support of the Pulmonary Autograft in the Ross Procedure
- 31 December 2009
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 18, S65-S66
Does Prior Percutaneous Coronary Intervention Adversely Affect Early and Long-term Survival After Coronary Artery Surgery?
- 31 December 2009
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 18, S65-S66
Does Prior Percutaneous Coronary Intervention Adversely Affect Early and Long-term Survival After Coronary Artery Surgery?